Rejected and unfilled prescriptions for new, more expensive cholesterol drugs tied to higher heart, stroke risk

Patients appear to be at higher risk of heart problems or stroke when prescriptions for the newest cholesterol-lowering drugs are rejected by insurance companies or unfilled by patients, according to new research in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.

source https://www.lifetechnology.com/blogs/life-technology-news-blog/rejected-and-unfilled-prescriptions-for-new-more-expensive-cholesterol-drugs-tied-to-higher-heart-stroke-risk